Skip to content

Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula

Tolerance and Compliance of Infants Fed an Extensively Hydrolyzed Infant Formula

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01573871
Enrollment
25
Registered
2012-04-10
Start date
2012-02-29
Completion date
2012-09-30
Last updated
2013-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Intolerance, Infant

Brief summary

The objective of the study is to assess gastrointestinal tolerance and compliance in infants who require a hydrolyzed formula.

Interventions

OTHERExperimental Hydrolyzed infant formula

Experimental hydrolyzed infant formula to be fed ad libitum

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 180 Days
Healthy volunteers
No

Inclusion criteria

* Infant is 0 to 180 days of age * Infant with persistent feeding intolerance symptoms; has had at least 1 formula switch OR infant is experiencing/being managed with an extensively hydrolyzed formula for suspected food protein intolerance or allergy or other condition where an extensively hydrolyzed formula is deemed appropriate * Infant has not consumed an extensively hydrolyzed infant formula * Use of prescription medications, OTC medications, home remedies, herbal preparations or rehydration fluids restricted * Infant is not receiving steroids. * Parent(s) confirm their intention to feed their infant the study product as the sole source of nutrition for the duration of the study * Parent(s) confirm their intention not to administer solid foods or juices to their infant through the duration of the study. * Parent(s) confirm their intention not to administer vitamin or mineral during the study

Exclusion criteria

• Participation in another study

Design outcomes

Primary

MeasureTime frame
Weight maintenance14 days

Secondary

MeasureTime frame
Formula volume intake14 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026